Statistics for The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
Total visits
| views | |
|---|---|
| The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity | 110 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 3 |
File Visits
| views | |
|---|---|
| Edwards_MultiSpecific.pdf | 79 |
Top country views
| views | |
|---|---|
| United States | 62 |
| Sweden | 9 |
| China | 6 |
| Japan | 4 |
| Poland | 3 |
| Vietnam | 3 |
| United Kingdom | 2 |
| Slovenia | 2 |
| Czechia | 1 |
| Spain | 1 |
| France | 1 |
| Netherlands | 1 |
Top city views
| views | |
|---|---|
| Oakland | 17 |
| Fairfield | 10 |
| Houston | 8 |
| Ashburn | 6 |
| San Diego | 4 |
| Tokyo | 4 |
| Beijing | 3 |
| Cambridge | 3 |
| Hanoi | 3 |
| Wroclaw | 3 |
| Andover | 2 |
| Mountain View | 2 |
| Amsterdam | 1 |
| Ann Arbor | 1 |
| Lewes | 1 |
| Madrid | 1 |
| Menlo Park | 1 |
| Redmond | 1 |
| Wilmington | 1 |